Mark J. Alles, Director at Syros Pharmaceuticals, Inc. (SYRS), bought 10,000 shares at $8.86 ($89K) on 2020-05-13, disclosed to the SEC on 2020-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CELG | BUY | 2018-05-17 | $200K | — | Filing → |
| CELG | BUY | 2018-02-08 | $300K | — | Filing → |
| CELG | SELL | 2015-02-10 | $14.1M | — | Filing → |